Establishing a Sustainable Gene Therapy Pipeline for Inherited Retinal Diseases

Time: 10:00 am
day: Day Two


  • Challenges and solutions for creating a sustainable gene therapy pipeline for rare
    inherited retinal diseases
  • Opus Genetics’ gene therapy portfolio for LCA and other classes of IRDs
  • Outlining phase I clinical trial data for LCA5-IRD